Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease.
D000690:Amyotrophic Lateral Sclerosis / Q000503:physiopathology* / Q000517:prevention & control; D000818:Animals; D001480:Basal Ganglia Diseases / Q000503:physiopathology* / Q000517:prevention & control; D004195:Disease Models, Animal; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology*; D016166:Free Radical Scavengers / Q000494:pharmacology*; D006801:Humans; D008959:Models, Neurological; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010302:Parkinson Disease, Secondary / Q000503:physiopathology; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology
D016166:Free Radical Scavengers; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate